United States Biodefense Market Report 2017

August 2017 | 106 pages | ID: U742AEC64D3EN
QYResearch

Abstracts

In this report, the United States Biodefense market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Biodefense in these regions, from 2012 to 2022 (forecast).

United States Biodefense market competition by top manufacturers/players, with Biodefense sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• Emergent Biosolutions
• Hytest
• GSK
• Sanofi
• PharmAthene
• Bavarian Nordic
• SIGA Technologies
• Arbutus Biopharma
• DynPort Vaccine
• Xoma Corporation
• Ichor Medical Systems
• Aeolus Pharmaceuticals
• Achaogen
• Elusys Therapeutics
• Dynavax Technologies
• Cleveland BioLabs
• Soligenix
• Alnylam Pharmaceuticals

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into

• Anthrax
• Smallpox
• Botulism
• Radiation/Nuclear

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Biodefense for each application, including

• Industry
• Chemical

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States Biodefense Market Report 2017

1 BIODEFENSE OVERVIEW

1.1 Product Overview and Scope of Biodefense
1.2 Classification of Biodefense by Product Category
  1.2.1 United States Biodefense Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Biodefense Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 Anthrax
  1.2.4 Smallpox
  1.2.5 Botulism
  1.2.6 Radiation/Nuclear
1.3 United States Biodefense Market by Application/End Users
  1.3.1 United States Biodefense Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Industry
  1.3.3 Chemical
1.4 United States Biodefense Market by Region
  1.4.1 United States Biodefense Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Biodefense Status and Prospect (2012-2022)
  1.4.3 Southwest Biodefense Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Biodefense Status and Prospect (2012-2022)
  1.4.5 New England Biodefense Status and Prospect (2012-2022)
  1.4.6 The South Biodefense Status and Prospect (2012-2022)
  1.4.7 The Midwest Biodefense Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Biodefense (2012-2022)
  1.5.1 United States Biodefense Sales and Growth Rate (2012-2022)
  1.5.2 United States Biodefense Revenue and Growth Rate (2012-2022)

2 UNITED STATES BIODEFENSE MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Biodefense Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Biodefense Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Biodefense Average Price by Players/Suppliers (2012-2017)
2.4 United States Biodefense Market Competitive Situation and Trends
  2.4.1 United States Biodefense Market Concentration Rate
  2.4.2 United States Biodefense Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Biodefense Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES BIODEFENSE SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Biodefense Sales and Market Share by Region (2012-2017)
3.2 United States Biodefense Revenue and Market Share by Region (2012-2017)
3.3 United States Biodefense Price by Region (2012-2017)

4 UNITED STATES BIODEFENSE SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Biodefense Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Biodefense Revenue and Market Share by Type (2012-2017)
4.3 United States Biodefense Price by Type (2012-2017)
4.4 United States Biodefense Sales Growth Rate by Type (2012-2017)

5 UNITED STATES BIODEFENSE SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Biodefense Sales and Market Share by Application (2012-2017)
5.2 United States Biodefense Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES BIODEFENSE PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Emergent Biosolutions
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Biodefense Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Emergent Biosolutions Biodefense Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Hytest
  6.2.2 Biodefense Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Hytest Biodefense Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 GSK
  6.3.2 Biodefense Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 GSK Biodefense Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Sanofi
  6.4.2 Biodefense Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Sanofi Biodefense Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 PharmAthene
  6.5.2 Biodefense Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 PharmAthene Biodefense Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Bavarian Nordic
  6.6.2 Biodefense Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Bavarian Nordic Biodefense Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 SIGA Technologies
  6.7.2 Biodefense Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 SIGA Technologies Biodefense Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Arbutus Biopharma
  6.8.2 Biodefense Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Arbutus Biopharma Biodefense Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 DynPort Vaccine
  6.9.2 Biodefense Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 DynPort Vaccine Biodefense Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Xoma Corporation
  6.10.2 Biodefense Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Xoma Corporation Biodefense Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 Ichor Medical Systems
6.12 Aeolus Pharmaceuticals
6.13 Achaogen
6.14 Elusys Therapeutics
6.15 Dynavax Technologies
6.16 Cleveland BioLabs
6.17 Soligenix
6.18 Alnylam Pharmaceuticals

7 BIODEFENSE MANUFACTURING COST ANALYSIS

7.1 Biodefense Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Biodefense

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Biodefense Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Biodefense Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES BIODEFENSE MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Biodefense Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Biodefense Sales Volume Forecast by Type (2017-2022)
11.3 United States Biodefense Sales Volume Forecast by Application (2017-2022)
11.4 United States Biodefense Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Biodefense
Figure United States Biodefense Market Size (K MT) by Type (2012-2022)
Figure United States Biodefense Sales Volume Market Share by Type (Product Category) in 2016
Figure Anthrax Product Picture
Figure Smallpox Product Picture
Figure Botulism Product Picture
Figure Radiation/Nuclear Product Picture
Figure United States Biodefense Market Size (K MT) by Application (2012-2022)
Figure United States Sales Market Share of Biodefense by Application in 2016
Figure Industry Examples
Table Key Downstream Customer in Industry
Figure Chemical Examples
Table Key Downstream Customer in Chemical
Figure United States Biodefense Market Size (Million USD) by Region (2012-2022)
Figure The West Biodefense Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Biodefense Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Biodefense Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Biodefense Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Biodefense Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Biodefense Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Biodefense Sales (K MT) and Growth Rate (2012-2022)
Figure United States Biodefense Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Biodefense Market Major Players Product Sales Volume (K MT) (2012-2017)
Table United States Biodefense Sales (K MT) of Key Players/Suppliers (2012-2017)
Table United States Biodefense Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Biodefense Sales Share by Players/Suppliers
Figure 2017 United States Biodefense Sales Share by Players/Suppliers
Figure United States Biodefense Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Biodefense Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Biodefense Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Biodefense Revenue Share by Players/Suppliers
Figure 2017 United States Biodefense Revenue Share by Players/Suppliers
Table United States Market Biodefense Average Price (USD/MT) of Key Players/Suppliers (2012-2017)
Figure United States Market Biodefense Average Price (USD/MT) of Key Players/Suppliers in 2016
Figure United States Biodefense Market Share of Top 3 Players/Suppliers
Figure United States Biodefense Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Biodefense Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Biodefense Product Category
Table United States Biodefense Sales (K MT) by Region (2012-2017)
Table United States Biodefense Sales Share by Region (2012-2017)
Figure United States Biodefense Sales Share by Region (2012-2017)
Figure United States Biodefense Sales Market Share by Region in 2016
Table United States Biodefense Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Biodefense Revenue Share by Region (2012-2017)
Figure United States Biodefense Revenue Market Share by Region (2012-2017)
Figure United States Biodefense Revenue Market Share by Region in 2016
Table United States Biodefense Price (USD/MT) by Region (2012-2017)
Table United States Biodefense Sales (K MT) by Type (2012-2017)
Table United States Biodefense Sales Share by Type (2012-2017)
Figure United States Biodefense Sales Share by Type (2012-2017)
Figure United States Biodefense Sales Market Share by Type in 2016
Table United States Biodefense Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Biodefense Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Biodefense by Type (2012-2017)
Figure Revenue Market Share of Biodefense by Type in 2016
Table United States Biodefense Price (USD/MT) by Types (2012-2017)
Figure United States Biodefense Sales Growth Rate by Type (2012-2017)
Table United States Biodefense Sales (K MT) by Application (2012-2017)
Table United States Biodefense Sales Market Share by Application (2012-2017)
Figure United States Biodefense Sales Market Share by Application (2012-2017)
Figure United States Biodefense Sales Market Share by Application in 2016
Table United States Biodefense Sales Growth Rate by Application (2012-2017)
Figure United States Biodefense Sales Growth Rate by Application (2012-2017)
Table Emergent Biosolutions Basic Information List
Table Emergent Biosolutions Biodefense Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Emergent Biosolutions Biodefense Sales Growth Rate (2012-2017)
Figure Emergent Biosolutions Biodefense Sales Market Share in United States (2012-2017)
Figure Emergent Biosolutions Biodefense Revenue Market Share in United States (2012-2017)
Table Hytest Basic Information List
Table Hytest Biodefense Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Hytest Biodefense Sales Growth Rate (2012-2017)
Figure Hytest Biodefense Sales Market Share in United States (2012-2017)
Figure Hytest Biodefense Revenue Market Share in United States (2012-2017)
Table GSK Basic Information List
Table GSK Biodefense Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure GSK Biodefense Sales Growth Rate (2012-2017)
Figure GSK Biodefense Sales Market Share in United States (2012-2017)
Figure GSK Biodefense Revenue Market Share in United States (2012-2017)
Table Sanofi Basic Information List
Table Sanofi Biodefense Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Sanofi Biodefense Sales Growth Rate (2012-2017)
Figure Sanofi Biodefense Sales Market Share in United States (2012-2017)
Figure Sanofi Biodefense Revenue Market Share in United States (2012-2017)
Table PharmAthene Basic Information List
Table PharmAthene Biodefense Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure PharmAthene Biodefense Sales Growth Rate (2012-2017)
Figure PharmAthene Biodefense Sales Market Share in United States (2012-2017)
Figure PharmAthene Biodefense Revenue Market Share in United States (2012-2017)
Table Bavarian Nordic Basic Information List
Table Bavarian Nordic Biodefense Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Bavarian Nordic Biodefense Sales Growth Rate (2012-2017)
Figure Bavarian Nordic Biodefense Sales Market Share in United States (2012-2017)
Figure Bavarian Nordic Biodefense Revenue Market Share in United States (2012-2017)
Table SIGA Technologies Basic Information List
Table SIGA Technologies Biodefense Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure SIGA Technologies Biodefense Sales Growth Rate (2012-2017)
Figure SIGA Technologies Biodefense Sales Market Share in United States (2012-2017)
Figure SIGA Technologies Biodefense Revenue Market Share in United States (2012-2017)
Table Arbutus Biopharma Basic Information List
Table Arbutus Biopharma Biodefense Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Arbutus Biopharma Biodefense Sales Growth Rate (2012-2017)
Figure Arbutus Biopharma Biodefense Sales Market Share in United States (2012-2017)
Figure Arbutus Biopharma Biodefense Revenue Market Share in United States (2012-2017)
Table DynPort Vaccine Basic Information List
Table DynPort Vaccine Biodefense Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure DynPort Vaccine Biodefense Sales Growth Rate (2012-2017)
Figure DynPort Vaccine Biodefense Sales Market Share in United States (2012-2017)
Figure DynPort Vaccine Biodefense Revenue Market Share in United States (2012-2017)
Table Xoma Corporation Basic Information List
Table Xoma Corporation Biodefense Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Xoma Corporation Biodefense Sales Growth Rate (2012-2017)
Figure Xoma Corporation Biodefense Sales Market Share in United States (2012-2017)
Figure Xoma Corporation Biodefense Revenue Market Share in United States (2012-2017)
Table Ichor Medical Systems Basic Information List
Table Aeolus Pharmaceuticals Basic Information List
Table Achaogen Basic Information List
Table Elusys Therapeutics Basic Information List
Table Dynavax Technologies Basic Information List
Table Cleveland BioLabs Basic Information List
Table Soligenix Basic Information List
Table Alnylam Pharmaceuticals Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Biodefense
Figure Manufacturing Process Analysis of Biodefense
Figure Biodefense Industrial Chain Analysis
Table Raw Materials Sources of Biodefense Major Players/Suppliers in 2016
Table Major Buyers of Biodefense
Table Distributors/Traders List
Figure United States Biodefense Sales Volume (K MT) and Growth Rate Forecast (2017-2022)
Figure United States Biodefense Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Biodefense Price (USD/MT) Trend Forecast (2017-2022)
Table United States Biodefense Sales Volume (K MT) Forecast by Type (2017-2022)
Figure United States Biodefense Sales Volume (K MT) Forecast by Type (2017-2022)
Figure United States Biodefense Sales Volume (K MT) Forecast by Type in 2022
Table United States Biodefense Sales Volume (K MT) Forecast by Application (2017-2022)
Figure United States Biodefense Sales Volume (K MT) Forecast by Application (2017-2022)
Figure United States Biodefense Sales Volume (K MT) Forecast by Application in 2022
Table United States Biodefense Sales Volume (K MT) Forecast by Region (2017-2022)
Table United States Biodefense Sales Volume Share Forecast by Region (2017-2022)
Figure United States Biodefense Sales Volume Share Forecast by Region (2017-2022)
Figure United States Biodefense Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources